PHARMA
Cipla - Short term pull back expected Cipla is showing negative divergences on a 15 minutes time frame.
Ideally, when price makes a new high and RSI fails to make a new high, it gives a good signal for a short term pullback.
However, pharma is in a strong bull rally, so entry and exit should be real quick.
Target 1 - 810
target 2 - 795
Sunpharma - Preparing for its Elliot wave 3Sun pharma is the biggest contributor in the Indian Pharma Index. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again.
Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point.
It completed its corrective wave (2) at 450 levels around September. It is all set to touch 630, 750 & 800 levels.
800 would be a crucial level to watch and any correction from those levels will be another buying opportunity.
Breakout above 518 and sustain can lead SunPharma till 545-550NSE:SUNPHARMA
Disclaimer: I am not SEBI registered person please contact your financial advisor before any investment decision.
SHORT OPPORTUNITY IN SUNPHARMAENTER WHERE THE MASSES HAVE THEIR STOP LOSS
TRAIL TO COST WHEN REWARD IS 70% OF THE RISK TAKEN.
RISK REWARD - 2:2
ALTHOUGH MARKET UNCERTAINTY IF FAR BEYOND MY ANALYSIS.
GOOD LUCK
TRADE AT YOUR OWN RISK!
inverted head and shoulders in sunpharmainverted head and shoulders spotted in sun pharma
pharma sector is showing positive signs nowadays
so this is a good buying opportunity
go long above ~518-219 target is easy 1% that is around 526
swing traders can take risk and go for a much bigger target
intraday people enter wisely
Moderna's vaccine results add approx. 10% to pre market pricePre market price at 98.9 is above 95 resistance after covid-19 vaccine test results.
Also all time high, which makes it bullish
PHARMA (30/11/2020) consolidating in ascending triangleIn H4, the stock is forming price action in ascending triangle pattern. Currently is consolidating between 5.42 and 5.80. A good entry would be after it breakout from the triangle @ EP 5.86 with Support at 5.38. TP is at 6.73 and new 52WH 8.25 (Fibo 1.272) - RRR 1:1.8
EP 5.86
TP 6.73 / 8.25
SL 5.38
Stochastic shows a pullback signal, MACD didn’t signal any breakout, and RSI didn’t show any good momentum for entry now.
PHARMA is one of market leader in Pharmaceutical sector with competitive balanced float (21% of 1440M shares) compared to its sector competitor AHEALTH (23% of 1780M shares). However, current vaccine sentiment will definitely help PHARMA in the long run.
TAYOR
Dr Reddy [Pharma Play]Stock has has been correcting for a while.
Nifty Pharma has also been correcting and could show rebound anytime soon.
Stock has taken strong support at 4800-4850 levels and has given a rebound as well.
Good time to start accumulating the stock.
MACD is has also given sign for reversal.
1st Target: 5330
2nd Target: 5500
SL@4700
MRK. Wait for pattern. and LONGMonthly
Uptrend
Weekly
Uptrend
Daily
range with no clear TP and orientirs
Trade possibe but with tight SL and speculative.
Wait for formation
Will Moderna break 86.7 resistance?Will MRNA break 86.7 based on it's Covid-19 vaccine work?
NOTE: Although not a recommendation, if you like my work, please donate a few coins. Thanks.
Major Wave Higher? Or down we go 🎩We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess?
Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
VLA [LONG] Covid CashNews looks positive for this company to produce a new vaccine for the UK, if proved safe would go global. A sound investment opportunity.
Can see it rising today.
AstrazenecaSo they had a death on the vaccine research and look to be forming a head and shoulder pattern which is typical of a reversal in price, how come the news always comes so in time? the markets are so fascinating.
Growth potentialThe pharmaceutical sector is one of the most interesting ones in such a troubled period.
I see some growth potential for $ACAD in the short term. It is showing a positive trend that is already consolidated and heading for a possible TP of around 44-45$
I see this level as an important resistance since it has been tested repeatedly in the past.
***As usual, not a trading advice, merely my view for informational and educational purposes only***
PHARM ; Possible bullish pullbackIf it stays above the support today, a buy signal will occur for Monday.
$CLVS Triangular TIPZ close to the X'zCLOVIS maker of FDA approved Rubraca® which is a treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapy. www.rubraca.com
Sitting at a pretty interesting area right now, sure it will get some more movement soon as we are at a crucial area. Plus last time I reviewed the sec docs it seemed to me like they were lowering net-losses & striving towards profits.
DYI: www.sec.gov
BIOCON:NSE - BULLISH FOR LONG -WITH CUP & HANDLE PATTERNWeekly chart shows very bullish from march this Year, Entry @ Rs 256 march 2020, I believe BIOCON will cross 800 by next March-April-2021.
Divis Laboratories Sell for TGT 2850RSI Divergence on Daily Chart
Window / Gap from Rs.2784 to Rs.3063
Considering Stock has closed around Rs.3050 for 2 consecutive day, any fall from hereon would cause the stock the to fall to Rs.2784 levels.
Suggestion: Sell a Call at CMP 3050 / 3000 with a SL Rs.3120.
